3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
2
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Prostatic Neoplasms
1
Neoplasms
1
Metastatic Non-Squamous Non-Small Cell Lung Cancer
1
Melanoma
1
Lung Neoplasms
1
Liposarcoma
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Advanced or Metastatic Solid Malignancies
1
Advanced Solid Tumors
1
Advanced Solid Tumor
1
Advanced Malignancies
1
Adenocarcinoma
1
Interventions
Cisplatin
136
Radiotherapy
90
Cetuximab
89
pembrolizumab
65
Fluorouracil
56
Docetaxel
56
Carboplatin
51
Paclitaxel
44
Radiotherapy, Intensity-Modulated
37
Nivolumab
35
durvalumab
19
Erlotinib Hydrochloride
18
Immunohistochemistry
16
Radiation
13
tremelimumab
12
Gemcitabine
11
Surgical Procedures, Operative
10
Gene Expression Profiling
10
Drug Therapy
10
Biopsy
10
Albumin-Bound Paclitaxel
10
Chemotherapy, Adjuvant
9
Capecitabine
9
Bevacizumab
9
atezolizumab
8
Radiosurgery
8
Polymerase Chain Reaction
8
Neoadjuvant Therapy
8
Ipilimumab
8
130-nm albumin-bound paclitaxel
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Squamous Cell Carcinoma of Head and Neck
×
sitravatinib
×
Clear all
NCT03575598
2023-07-27
SNOW
University Health Network, Toronto
Phase EARLY_PHASE1
Completed
10 enrolled